The grapefruit interaction is one of the most famous in clinical pharmacology, and one of the most overstated for many medications. For antipsychotics specifically, the picture is more nuanced: some are genuinely affected, others not at all. Knowing the difference is useful — both because grapefruit is a healthy food many people enjoy, and because for the few affected medications, the interaction can be substantial.
Grapefruit and grapefruit juice inhibit intestinal CYP3A4 — the enzyme that breaks down some antipsychotics — and can raise blood levels of lurasidone, quetiapine, pimozide, and (to a lesser extent) aripiprazole and brexpiprazole.
The pharmacology
Grapefruit contains a compound called bergamottin (and related furanocoumarins) that irreversibly inhibits CYP3A4 enzymes in the wall of the small intestine. Many oral medications are first metabolised in the gut wall before reaching systemic circulation; this "first-pass" metabolism normally reduces how much drug actually enters the blood. When grapefruit blocks the enzyme, more drug enters the blood, sometimes much more.
Critically, the inhibition is irreversible — the enzyme has to be re-synthesised by the gut, which takes about 24–72 hours. So the timing trick of "wait two hours after grapefruit" does not work for most patients. The effect lasts a day or more.
Grapefruit does not meaningfully affect liver CYP3A4, only intestinal. So drugs that are mainly metabolised by the liver and not the gut wall are less affected. And drugs that are metabolised by other CYP enzymes (CYP1A2, CYP2D6, CYP2C9, CYP2C19) are not affected at all by grapefruit.
Antipsychotics significantly affected by grapefruit
Lurasidone (Latuda)
Lurasidone is heavily metabolised by CYP3A4 in both the gut and liver. The FDA label for Latuda explicitly says to avoid grapefruit and grapefruit juice during treatment. Co-administration with strong CYP3A4 inhibitors is contraindicated, and grapefruit qualifies under that warning. Levels can rise substantially. This is the antipsychotic where the warning is most clear-cut.
Quetiapine (Seroquel)
Quetiapine is also a CYP3A4 substrate. Studies have shown that grapefruit juice can roughly double quetiapine plasma concentrations. For low-dose quetiapine (used off-label for sleep), this might just mean a more sedating night. For higher-dose quetiapine, it can produce excessive sedation, hypotension, and prolonged QT.
Pimozide
Pimozide is metabolised by CYP3A4 and is well-known for QT prolongation. The FDA label contraindicates strong CYP3A4 inhibitors and grapefruit juice for this reason. The interaction can produce dangerous arrhythmias.
Ziprasidone (Geodon)
Ziprasidone is partly CYP3A4-metabolised, but the major metabolic pathway is via aldehyde oxidase, which is not affected by grapefruit. The grapefruit interaction is therefore modest. However, ziprasidone has its own QT concerns, so caution is reasonable.
Aripiprazole and brexpiprazole
Both are partly metabolised by CYP3A4 and partly by CYP2D6. Strong CYP3A4 inhibitors can raise levels modestly. Grapefruit's effect is usually mild but worth knowing about for patients on the upper end of the dose range or those who are also CYP2D6 poor metabolisers.
Iloperidone
Metabolised by both CYP3A4 and CYP2D6. Strong CYP3A4 inhibitors raise levels and the FDA label recommends a dose reduction in such cases.
Antipsychotics not significantly affected by grapefruit
Clozapine
Primarily metabolised by CYP1A2, with smaller contributions from CYP2D6 and CYP3A4. Grapefruit's effect on clozapine levels is small — caffeine, smoking, and fluvoxamine matter much more.
Olanzapine
Mainly metabolised by CYP1A2 and direct glucuronidation. Grapefruit has minimal effect.
Risperidone and paliperidone
Risperidone is metabolised primarily by CYP2D6. Paliperidone is largely renally excreted with limited hepatic metabolism. Grapefruit has minimal effect on either.
Haloperidol
Metabolised by multiple pathways. Grapefruit interaction is not clinically meaningful.
Lumateperone (Caplyta)
Metabolised primarily by UGT enzymes and CYP3A4. Strong CYP3A4 inhibitors are contraindicated per the FDA label. Grapefruit warrants caution.
Practical points
- If you are on lurasidone or pimozide, avoid grapefruit and grapefruit juice entirely.
- If you are on quetiapine, especially at higher doses, avoid grapefruit or discuss with your prescriber.
- For most other antipsychotics, occasional grapefruit is unlikely to cause problems, but it is worth mentioning to your prescriber.
- Pomelo and Seville oranges (used in marmalade) have similar furanocoumarin content and similar effects. Sweet oranges, lemons, limes, and tangerines do not.
- Even half a grapefruit or a small glass of juice can produce the inhibitory effect; the dose-response is not linear.
What about other foods?
St. John's wort (a herbal supplement sometimes used for depression) is a strong CYP3A4 inducer and lowers blood levels of many antipsychotics. It is not safe to combine with most antipsychotic regimens without explicit prescriber awareness.
You experience excessive sedation, dizziness, palpitations, or confusion after consuming grapefruit while on lurasidone, pimozide, or higher-dose quetiapine.
The bottom line
Grapefruit is not a universal antipsychotic enemy. For most antipsychotics it does little. For a small but important group — lurasidone in particular — it is genuinely contraindicated. Reading the medication label or asking the pharmacist is a five-second check that prevents a real but easily avoidable problem.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.